| |
|
|
|
|
|
|
|||
|
Blood, Vol. 111, Issue 7, 3735-3741, April 1, 2008
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance Files in this Data Supplement:
| |||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||